Skip to main content
Equibles

FRONTIER CAPITAL MANAGEMENT CO LLC

Position in CRL — Charles River Laboratories International, Inc.

CIK 351173 Boston, MA
Back to CRL Full portfolio

Position in CRL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$11,552,229
+$3,261,534 QoQ
Shares Held
50,938
+6.0% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#100
of 571 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 76% Shared 0% None 24%

Common Shares in CRL Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

FRONTIER CAPITAL MANAGEMENT CO LLC holds $144,413,741 across 8 Diagnostics & Research names. CRL ranks #7 (8.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NTRA
Natera, Inc.
 173,547 $47,109,333
2 RVTY
Revvity, Inc.
 180,771 $20,112,581
3 ICLR
Icon PLC
 104,335 $18,124,032
4 IDXX
Idexx Laboratories Inc /De
 33,592 $17,684,172
5 MTD
Mettler Toledo International Inc/
 12,655 $16,166,889
6 A
Agilent Technologies, Inc.
 100,214 $13,311,425
7 CRL
Charles River Laboratories International, Inc.
This page 		50,938 $11,552,229
8 LH
Labcorp Holdings Inc.
 1,261 $353,080

All Filings in CRL

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,552,229 50,938
2026-03-31 $8,290,695 48,062
2025-12-31 $24,675,875 123,701
2025-09-30 $7,866,026 50,275
2025-06-30 $7,859,765 51,801
2025-03-31 $10,697,757 71,072
2024-12-31 $13,515,489 73,215
2024-09-30 $14,447,355 73,348
2024-06-30 $15,365,626 74,381
2024-03-31 $18,458,739 68,126
2023-12-31 $12,085,477 51,123
2023-09-30 $9,291,803 47,412
2023-06-30 $5,747,394 27,336
2023-03-31 $5,573,259 27,615
2022-12-31 $6,560,315 30,107